Passer au contenu principal

Subventions financées

Filtrer par:
Effacer les filtres
Filtrer par:

2 résultats trouvés

Amyloid beta oligomers: refining the therapeutic target through photolabelling and fractionation

We know that Alzheimer’s disease is caused by the clumping together of misfolded proteins in the brain, specifically two proteins called amyloid beta and tau.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Alberta
DATE DE DÉBUT
2024

Correlating quaternary structure of pathological protein aggregates with phenotypic presentation of ALS

Amyotrophic lateral sclerosis (ALS) is a disease of progressive weakness that leads to death within a few years of onset.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Québec
DATE DE DÉBUT
2024